Unlike classical hairy cell leukemia (HCL-c), HCL-v typically lacks the BRAF V600E mutation, thereby limiting the use of BRAF inhibitors and complicating treatment strategies (4). The gene discussed is BRAF; the disease is hairy cell leukemia.